Tannins are considered as valuable plant secondary metabolites providing many benefits for human health. In this review information was gathered about bioactivity in vitro and in vivo, as well as about conducted clinical trials. The literature research was based on ScienceDirect, Scopus, and Cochrane databases and presents a wide range of tested activities of tannins. The described clinical trials verify laboratory tests and show the effective health benefits taken from supplementation with tannins.
Introduction
Tannins are polyphenolic secondary metabolites of higher plants and are both galloyl esters and their derivatives, in which galloyl moieties or their derivatives are attached to a variety of polyol-, catechin-and triterpenoid cores, or they are oligomeric and polymeric proanthocyanidins that can possess different interflavanyl coupling and substitution patterns [1] . The classical concept for tannins classification is based on their resistance to hydrolysis caused by hot water or tannases. Hydrolysable tannins encompass polyesters of gallic and hexahydroxydiphenic acid (gallotannins and ellagitannins, respectively), whereas condensed tannins include oligomers and polymers composed of flavan-3-ol nuclei (proanthocyanidins) [2] . In the new approach tannins are divided according to their structural characteristics into four major groups: gallotannins, ellagitannins, complex tannins and condensed tannins [1] . Another important classification of tannins is related to stability of the chemical structure. Tannins and polyphenols related to tannins can be categorized as polyphenols of constant chemical structure (Type A) and polyphenols of variable composition (Type B). Constancy in the chemical structure and composition is essential for characterizing the biological and pharmacological properties of any target compound [3] .
Bioactivity of tannins
There are a lot of epidemiological data which suggest that tannins are useful in external treatment of skin inflammation and injuries and that intake of tannins may prevent the onset of chronic diseases [4] . Biological effects of tannins have been extensively studied using various in vitro or animal models, however, clinical data on humans is still limited to several plant extracts. Tannins may exert their biological effects in two different ways: as an unabsorbable, complex structure with binding properties which may produce local effects in the gastrointestinal tract (antioxidant, radical scavenging, antimicrobial, antiviral, antimutagenic, and antinutrient), or as absorbable tannins (low-molecular-weight) and absorbable metabolites from colonic fermentation of tannins that may produce systemic effects in various organs [4] .
Bioactivity in vitro
Antioxidant and radical scavenging properties: Tannins are known to inhibit lipid peroxidation in vitro and have the ability to scavenge free radicals important in cellular prooxidant states. Most of the activities of tannins, including their free radical-scavenging capacity, largely depend on their structure and degree of polymerization [5, 6] . Lipid peroxidation in rat liver mitochondria stimulated by adenine 5'-diphosphate and ascorbic acid was most potently inhibited by the ellagitannin pedunculagin (Figure 1 ), a molecule possessing two hexahydroxydiphenyl groups. Complex tannins, such as epigallocatechingallate (EGCG) (Figure 2 ), also displayed potent activity. Lipid peroxidation caused by the xanthinxanthine oxidase system in the cell membranes of mouse eye lens, was strongly inhibited by several tannins among which were the hydrolysable tannins pentagalloylglucose ( Figure 3 ) and geraniin ( Figure 1 ) [5] . Highly condensed kaki-tannin significantly inhibited the auto-peroxidation of lipid in the liver homogenates from healthy mice and in the induced liver homogenate lipid oxidation model. What is more, it was estimated that kaki-tannin was 100-times more active as an inhibitor of autooxidation or induced oxidation than grape seed proanthocyanidins [7] . However, procyanidins B1 and B3 ( Figure 4 ) exhibited stronger antioxidant activity than ascorbic acid and α-tocopherol for linoleic acid in aqueous systems [8] . An increase in the antiradical power is observed with the degree of polymerization of proanthocyanidins up to seven [16] . Potent in vitro scavenging effects were exhibited also in the 2,2-diphenyl-1picrylhydrazyl (DPPH) test by the hydrolysable tannins: pentagalloyl-glucose ( Figure 3 ), tellimagrandins I and II, pedunculagin, isoterchebin, mallotusinic acid, geraniin and chebulinic acid (Figure 1 ), whereas the effects of low molecular weight polyphenols, except for EGCG and epicatechingallate (ECG), were low [5] .
Antimicrobial activity: Tannins seem to affect bacterial growth in several ways, such as inhibition of extracellular microbial enzymes, deprivation of the substrates required for microbial growth or direct action on microbial metabolism through inhibition of oxidative phosphorylation [9] . Complexation of metal ions in the bacterial growth environment by tannins could also be a mechanism of their antimicrobial action [3] .
Antibacterial activity of tannins has been described for several human gastrointestinal pathogens. Ellagitannins proved to be strong inhibitors of Staphylococcus bacteria, Candida albicans and Campylobacter jejuni [4] . Tea catechins have been tested for antibacterial activity against Helicobacter pylori. Among several compounds: (+)catechin (C), (−)epicatechin (EC), (−)epigallocatechin (EGC) (Figure 2 ), ECG and EGCG; only EGCG and ECG exhibited antibacterial activity against H. pylori at the 100 µg/mL concentration level [10] . However, in another study catechin has been shown to display a dose and time dependent growth inhibitory effect (as measured either in liquid culture medium or in semisolid agar plates) for H. pylori and Escherichia coli [11, 12] . Funatogawa and coworkers, who studied a wide range of tannins against H. pylori, described that hydrolysable tannins and acid-treated hydrolysable tannins demonstrated promising activity. Hydrolysable tannin monomers revealed stronger activity than oligomers and catechins. Procyanidins demonstrated minimal antibacterial activity against H. pylori, with a few exceptions. Significant activity of hydrolysable tannins may be attributed to their higher watersolubility. What is more, acid-treatment hardly affected the antibacterial activity of hydrolysable tannins in vitro, suggesting that they can work in the acidic gastric environment. Hydrolysable tannins did not affect the viability of gastric epithelial cells and may have a narrow antibacterial spectrum since they demonstrated no antibacterial activity against E. coli, which is a normal inhabitant of the human intestinal tract [13] . Gallotannins were described as active inhibitors of water-insoluble glucan synthesis leading to bactericidal effects on Streptococcus mutans, S. salivarius, and Actinomyces viscosus [14, 15] . Flavan-3-ol monomers such as (+)catechin and EC may be capable of influencing the large intestinal bacterial population, even in the presence of other nutrients, such as carbohydrates and proteins. It was found that (+)catechin has regulatory properties because it significantly inhibited growth of Clostridium histolyticum and enhanced growth of E. coli and members of the Clostridium coccoides -Eubacterium rectale group. The growth of Bifidobacterium and Lactobacillus spp. remained relatively unaffected [16, 17] .
The synergistic effects of ellagitannins and antibiotics against antibiotic-resistant bacteria are one of the most noticeable antimicrobial activities of tannins. Several dimeric tannins showed anti-bacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) and lowered the resistance to oxacillin of this microorganism. The complex tannin theasinensin A ( Figure 2 ) caused a noticeable reduction in MIC values of oxacillin for the MRSA strains. Oxacillin in the presence of theasinensin A completely inhibited cell growth over 10 hours. Similar reduction of resistance to oxacillin was observed with the tea polyphenol (-)-epicatechingallate, procyanidins B3 and B4 and for the hydrolysable tannins tellimagrandin I, rugosin B and corilagin ( Figure 1 ). Theasinensin A was also effective in reducing the MIC values of the other β-lactams, penicillin G and ampicillin, as well as an aminoglycoside antibiotic, streptomycin. Two procyanidins, B3 and B4 (Figure 4 ), lowered the MIC of penicillin G, whereas oenothein B (Figure 1 ), a macrocyclic ellagitannin dimer suppressed the antibiotic resistance of MRSA [18, 19] .
Interesting antimicrobial activity known for cranberry juice has been associated with inhibition of E. coli adherence to human uroepithelium [20] . This activity is attributed to cranberry
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Antiviral activity: Tannins have the ability to interact with multiple viral targets. It has been demonstrated by radiolabelled virus particles of Herpes simplex that the antiviral effects of hydrolysable and galloylated condensed tannins were due to inhibition of virus adsorption [22] . The antiherpetic activities of hydrolysable tannins were dependent on the number of either galloyl or hexahydroxydiphenoyl groups, while those of condensed tannins increased with the degree of condensation [23] . Potent anti-human immune-deficiency virus (HIV) activities were found for the dimeric ellagitannins oenothein B, coriariin A, and agrimoniin ( Figure 1 ). Anti-HIV activity was at least partly mediated by adsorption inhibition [18] . Other authors have suggested that the inhibition in adsorption may be derived from its binding to components of the viral envelope (in influenza A virus, parainfluenza virus, herpes virus type 1 and 2 and hepatitis A), resulting in inhibition of viral attachment and penetration of the plasma membrane [24] .
The ellagitannin casuarinin ( Figure 1 ) was also found to possess anti-herpes virus activity in inhibiting viral attachment to cells and viral penetration, and also disturbing the late event(s) of infection. [25] . Other hydrolysable tannins, chebulagic acid and punicalagin were effective in abrogating infection by human cytomegalovirus (HCMV), hepatitis C virus (HCV), dengue virus (DENV), measles virus (MV), and respiratory syncytial virus (RSV), at micromolar concentrations and in dose-dependent manners without significant cytotoxicity. Moreover, these natural compounds inhibited viral attachment, penetration, and spread to different degrees for each virus. Specifically, the tannins blocked all these steps of infection for HCMV, HCV, and MV [26] . Hydrolysable tannins possess remarkable HCV protease inhibitory activities. Casuarinin and chebulagic acid are non-protein and non-peptidomimetic inhibitors of HCV protease [27] . It has also been demonstrated that ellagitannins and several condensed tannins are potent inhibitors of reverse transcriptase [28] .
Cardioprotective activity: Tannins have cardioprotective activity via stabilization of pericardial tissue [29] , inhibition of enzymatic degradation of elastin [30] and reduction of the calcification of glutaraldehyde-fixed aortic wall [31] . Hydrolysable tannins, in particular, have anti-ischemic activity and an endotheliumdependent vasorelaxant effect through the interplay of different factors such as cyclooxygenase pathway activation, TNF-alpha inhibition, endothelial nitric oxide synthase activation, and scavenging of free radical and reactive oxygen species [32] . It was shown that extracts and purified tannins of Geum japonicum L. (hydrolysable tannins) caused NO-and cGMP mediated potent vasorelaxation in rat aortic rings that had been pre-contracted with the α1-adrenergic receptor agonist phenylephrine. The phenolic hydroxyl groups of penta-O-galloyl-β-glucoside are essential for its vasorelaxant effects, because this structure without the hydroxyl groups, does not cause vasorelaxation. The G. japonicum extract markedly reduced arterial blood pressure of hypertensive and normotensive rats in an NO-dependent manner [33] . Similarly, tannic acid relaxed precontracted human coronary arteries and rat aortic rings in an endothelium and NO-dependent manner, accompanied by an increase in vascular GMP levels [34] . Hydrolysable tannins possess an inhibitory effect on propranololinduced negative inotropism, and the relative order of potency of the tested hydrolysable tannins (praecoxin, 1-desgalloyl rugosin F) indicates that the galloyl group in the tannin structure is crucial for the negative inotropic action [35] .
Proanthocyanidins possess long-lasting antihypertensive and vasorelaxing properties linked to endothelium-related factors in which nitric oxide is involved [36] , and also a significant effect in the protection of heart against myocardial infarction induced by isoproterenol [37] . In rabbit pulmonary artery, condensed tannin prepared from cotton bract endothelium-dependently relaxed the norepinephrine pre-contracted vessels, presumably via formation of endothelium-derived relaxing factor [38] .
Histamine release inhibition:
The inhibitory activity of hydrolysable tannins on O 2 -induced histamine release depends on the number and composition of galloyl groups, HHDP groups and its analogs, but not simply on the number of phenolic hydroxyl groups [39] . Geraniin (Figure 1 ), a typical monomeric hydrolysable tannin with an HHDP group, a galloyl and a DHHDP group in the molecule, showed a significant inhibition of K0 2 -induced histamine release. However, the inhibitory effects of the other monomeric hydrolysable tannins were less potent. Most of the dimeric hydrolysable tannins exhibited stronger effects on K0 2 induced histamine release. Agrimoniin, euphorbin C and oenothein B (Figure 1 ), which have unique structures with several HHDP groups, the euphorbinoyl group or macroring, respectively, showed the most potent activity [39] .
Cytotoxic activity: Procyanidins have been reported to be more cytotoxic than monomer flavanols to a variety of human cancer cell lines. Many studies that have compared the effectiveness of various monomer flavanols indicate that the presence of a galloyl residue on the 3 position of the C-ring enhances the cytotoxicity of these compounds [40] . The potential anticancer properties evaluated for dimer procyanidins that contain galloyl groups, digalloyl dimer B1 and B2 (Figure 4 ) esters in a number of human cancer cell lines was associated with a reduction in cell number and an inhibition of cell proliferation. Digalloyl dimer procyanidins exerted significantly higher cytotoxic effects than the structurally related complex tannins: EC, C, ECG, EGCG, (−)-catechingallate (CG) and procyanidins B1 and B2 (Figures 2 and 4) . These results support the concept that the incorporation of galloyl groups and the oligomerization of flavanols enhances the cytotoxic effects of typical monomer flavanols [40] .
In laboratory tests, the catechins present in tea leaves have been shown to inhibit the growth of cancer cells. Experimental studies demonstrate that anti-cancer activity is likely to be the result of the antioxidant activity and the direct binding of green tea polyphenols to proteins, resulting in the modulation of multiple cellular signaling pathways [41] . Another way of altering the cancer cells is inhibition of the release of tumor necrosis factor-α (TNF-α). This activity was observed for the hydrolysable tannins geraniin and corilagin ( Figure  1) in an assay for screening cancer-preventive agents suggesting that tannins of various structures could prevent cancer [5] . Antitumor activities have been shown in studies using purified ellagitannins: sanguiin H6 and lambertianin. Moreover, an apple polyphenols extract rich in proanthocyanidins effectively suppressed epidermal growth factor receptor phosphorylation, inhibiting the growth of human colon carcinoma cell line HT29 in vitro [4] .
Antidiabetic activity: Tannins possess antidiabetic potential firstly due to their ability to lower glucose levels by delaying intestinal glucose absorption and an insulin-like effect on insulin-sensitive tissues and secondly by delaying the onset of insulin-dependent diabetes mellitus by regulating the antioxidant environment of pancreatic β-cells [4] .The lowering of glucose levels can be obtained by the inhibition of α-amylase and α-glucosidase activity. Hydrolysable tannins (HT): vescalagin, acutissimin A/B (Figure 3 ), epiacutissimin A/B, grandinin/roburin E, hexagalloyl glucose ( Figure 3 ) and heptagalloyl glucose have been reported to inhibit αamylase in the in vitro human starch digestion model [42] . The type of enzyme inhibition was mixed non-competitive. Moreover, the inhibitory activity of HT was significantly enhanced in the absence of proteins in the food matrix, and was also highly dependent on the sequence of addition of the enzyme and substrate to HT. Preincubation of α-amylase with HT prior to addition of substrate resulted in a significantly stronger inhibitory activity [42] . Another in vitro and in silico investigation of inhibition of human pancreatic α-amylase showed activity of catechins which followed the order: (+)-gallocatechin-3-O-gallate > ECG > EGCG > EC > EGC > C. The galloylated catechins have higher binding affinity with αamylase than non-galloylated catechins [43] . It has been suggested that the interaction between tannins, such as galloylated quinic acid, and human α-amylase depends on the free hydroxyl groups on the tannins that are able to participate in hydrogen bonding [44] . Tannins have also been shown to inhibit intestinal α-glucosidase activity effectively,with Ki values in the same range as that of synthetic inhibitors (acarbose and voglibose), which are already being used therapeutically to control non-insulin-dependent diabetes mellitus [45] . The extent of inhibition of α-glucosidase is related to the proanthocyanidin content, while α-amylase inhibition is caused by hydrolysable tannins [46] . An insulin-like effect on insulinsensitive tissues has recently been suggested for tannins which act on cells by modifying or interacting with specific proteins of important intracellular signaling pathways and hence also affecting their role in improving hyperglycemia. Grape seed procyanidin extracts have exhibited insulinomimetic properties in vitro [4, 47] .
Antiobesity effects:
Laboratory studies indicate that the antiobesity effects of polyphenol-rich diets may be attributed to the ability of polyphenols to interact, directly or indirectly, with adipose tissues (preadipocytes, adipose stem cells and immune cells). The antiobesity potential of green tea catechins, particularly EGCG, has been shown in cell culture. EGCG (10-100 μM), and EC and EGC (with lower potencies) induced dose-and time-dependent decreases in adipocyte viability [48] and cell cycle arrest at the G0/G1 phase [49] . At lower concentrations (0-10 μM), EGCG induced G2/M growth arrest in a dose-dependent manner in mature adipocytes [50] . Concurrently, EGCG (0-400 μM) and, less potently, ECG, EGC and other catechins, induced apoptosis in murine preadipocytes [51] and mature adipocytes [52] and increased caspase-3 activity [51] . Furthermore, EGCG (0.5-10 μM) inhibited preadipocyte differentiation and, at higher concentrations (50-200 μM), cellular triglyceride (TG) accumulation in adipocytes in a dose-and time-dependent manner [53] . Also 1,2,3,4,6-penta-Ogalloyl-β-D-glucopyranose (β-PGG) and its natural anomer, α-PGG, stimulated glucose transport in adipocytes by directly binding to the insulin receptor. α-PGG did not bind to the insulin-binding site of the insulin receptor, but to another site located on the α-subunit of the insulin receptor. The binding of α-PGG to the insulin receptor displaced insulin from the insulin-binding site [54] .
Antiinflammatory and wound healing properties: Ellagitannins (geraniin, corilagin, furosin) ( Figure 1 ) from aqueous extracts of Phyllanthus muellerianus have been reported as active compounds with strong wound-healing properties (stimulating effects against human keratinocytes and dermal fibroblasts) [55] . Also, for pentagalloylglucose (main constituent of Paeonia suffruticosa) and for trigalloyl-glucose and gallic acid from Terminalia chebula reports have been published on potential wound healing properties [56, 57] . Strong anti-hyaluronidase and anti-elastase activity was also described for lythri herba [58] Furthermore, local delivery of tannic acid prevents collagen matrix degradation by cross-linking fibrous collagen and inhibiting matrix metalloproteinase activity [59] .
Bioactivity in vivo
In in vivo experiments extracts, juices or fruits with described beneficial to health activity are mainly used.
Antiulcer activity: Tannins from Mouriri pusa were shown to exhibit cytoprotective and cicatrizing effects on gastric ulcers in rats. Reduction in ulcer formationin an acute model and augmentation of regenerative mucosa were obtained in a 14-day treatment with 25 mg/kg of the tannin fraction. The tannin fraction promoted a mechanical barrier that protected the stomach from ulcer formation and facilitated ulcer healing [60] .
Antioxidant activity: Administration of tannin rich cocoa to rats intoxicated with arsenic significantly protected against liver injury. The toxic effect of arsenic is mediated through the generation of reactive oxygen species (ROS) and ROS-driven oxidative stress. The tannin rich cocoa, administered by oral gavage for 4 weeks in doses ranging from 30 to 300mg/kg, increased the levels of superoxide dismutase and glutathione peroxidase activities by directly scavenging ROS, as well as by inhibiting lipid peroxidation [61] . Antioxidant effects were also obtained in obese-diabetic rats during the 4 weeks supplementation with cocoa extracts (600 mg/kg body weight/day). The decreased plasma oxidative stress biomarker and increased superoxide dismutase activity were results of the treatment [62] .
Antidiabetic activity: The oral administration of Syzygium cumini bark extract daily over a period of 45 days (300 mg/kg of body weight) significantly decreased blood glucose levels and increased levels of plasma insulin and C-peptide of both normal and diabetic rats [63] . Kaki-tannin prevented a rise in plasma total cholesterol, non-HDL cholesterol, triglycerides, and insulin in type 2 diabetic mice fed a high fat diet. Moreover, intake of kaki-tannin prevented fatty liver and induced the genes related to cholesterol metabolism [64] .
Antiinflammatory activity: The effect of corilagin ( Figure 1 ) on lung injury caused by bleomycin exposure was investigated in an animal model of pulmonary fibrosis. Corilagin abrogated bleomycininduced lung fibrosis, reduced the number of apoptotic lung cells and prevented lung epithelial cells from membrane breakdown. The release of pro-inflammatory cytokines was reversed significantly by high-dose corilagin (100 mg/kg i.p) and less dramatically by low dose (10 mg/kg i.p). This lung-protective effect was attributed to its anti-oxidative, anti-inflammatory and anti-apoptotic activities, as well as inhibition of TGF-β1 expression and ECM synthesis [65] .
Protecting effects on bone marrow hematopoietic stem cells:
Tannins in Sanguisorba root can effectively protect and treat cyclophosphamide-induced myelosuppression in mice. The tannin fraction was administered by oral gavage at a dose of 20 mg/kg for 10 days after ip administration of cyclophosphamide (200 mg/kg). The mechanism might be related to protecting hematopoietic stem cells of bone marrow, stimulating hematopoiesis recovery, as well as preventing the apoptosis of hematopoietic stem cells induced by cyclophosphamide. The effect may result by promoting cells in the G2/M phase into the G1 phase, and it could promote the production of DNA photolyase and repair the damaged DNA after chemotherapy damage [66] .
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Inhibition of skin-tumor promotion: The complex tannin, epigallocatechin gallate ( Figure 2 ) reduced a number of the tumor bearing mice treated with 7,12-dimethylbenzo[a]anthracene (DMBA) (a tumor initiator) plus teleocidin (a tumor promoter) to less than a quarter in the mice treated with combination of tumor initiator and promoter plus EGCG. The average number of tumors per mouse in the EGCG-treated mice was also reduced to about 5% [5] . Inhibition by hydrolysable tannin 1,2,3,4,6-penta-O-galloyl-β-D-glucose in a two-stage skin carcinogenesis assay using DMBA plus teleocidin reduced the percentage of tumor-bearing mice to about 50%, and the average number of tumors per mouse to ca. 33% [5] . Anti-tumor promoting activity was also described for tenophyllanin A and alienanin B, a C-glucosidic ellagitannin monomer and dimer in the two stage mouse skin carcinogenesis assay with DMBA and 12-O-tetradecanoylphorbol-13-acetate (TPA). These observations suggest that there may be other tannins that have anti-tumor promoting activity [5] .
Tumor inhibition in the gastrointestinal tract: Inhibition of tumor promotion in the gastrointestinal tract in a model system of mouse duodenal carcinogenesis with N-ethyl-N-nitro-N-nitrosoguanidine by feeding EGCG, resulted in the reduction of the number of tumorbearing mice to less than one-third of the control group. The number of tumors-per-mouse was also reduced to about one-third. EGCG was incorporated into the cytosol and the nuclei [5] . Apple proanthocyanidins and red wine proanthocyanidins have also been demonstrated to antagonize colon carcinoma promotion in vivo. In F344 rats with azoxymethane-induced colon carcinomas, red wine polyphenol-treated animals had a consistently lower tumor yield compared with the control. In animals with drinking water containing 0.01% apple proanthocyanidinsthe total number of hyperproliferative crypts and aberrant crypt foci was reduced by 50% showing that apple proanthocyanidins alter intracellular signaling pathways, polyamine biosynthesis and trigger apoptosis in tumor cells [4] . A tannin-rich diet may therefore have positive local health effects in the colon.
Host-mediated antitumor activity of ellagitannin oligomers:
The tumor growth inhibiting effect achieved by administration either before or after intraperitoneal inoculation of tumor cells was exhibited by several ellagitannin macrocyclic oligomers, such as oenotheins A and B, camelliin B and woodfordins C, D, E and F. The most notable inhibitory effect was found for the macrocyclic dimers oenothein B and woodfordin C, macrocyclic trimers oenothein A and woodfordin D, and the macrocyclic tetramer woodfordin F. The effect is attributable to the immune response of host animals, as shown by stimulation of interleukin 1 (IL-1) production from human peripheral macrophages by these ellagitannin oligomers. The activity of dehydroellagitannins, as either monomers or dimers, was weak. However acyclic dimers, such as agrimoniin, coriariin A and C, cornusiin A, hirtellins A and B, rugosins D and E, isorugosin D and tamarixinin A possessed some activity. Among the monomers, only tellimagrandin II was active [5, 18] .
Clinical trials
As shown in the previous sections tannins have been widely investigated in order to find their potential health benefits. Pure tannins, as well as extracts and beverages, have been subjected to clinical trials on humans. The influence of tannins on metabolic syndrome, cardiovascular disease, plasma lipid profiles and inflammation has been studied.
Green tea: Green tea has long been the beverage and medicine of choice within Asian countries and has recently sparked the interest of Western societies due to its polyphenolic content. The effect of green tea administration on metabolic syndrome and obesity-related parameters has been reported in a number of human studies since 1999. Green tea was given to fourteen normal healthy persons (mean age 30 years) to elucidate its effect on certain constituents of the metabolic syndrome. Arterial blood flow and cytokine measurements after taking either a 6 g dose of green tea or a 125mg dose of caffeine (amount of caffeine in 6 g of green tea) revealed that flow-mediated dilation of the brachial artery, a predictor of cardiovascular disease, was improved with green tea but not with caffeine alone [67] . One hundred and thirty-two obese individuals (average BMI 32.2 kg/m 2 ) drank a beverage containing either 625 mg of green tea catechins or a placebo daily for 3 months. Subjects drinking the green tea extract did not lose more weight, but they had slightly lower triacylglycerol levels [68] . Sixty subjects 32 to 73 years of age who had serum hyperglycemia consumed a tea with 544 mg/day of polyphenols for 2 months in a crossover study. The individuals who drank the tea showed a modest but significant lowering of glycated hemoglobin [69] . However, another trial did not show a benefit of green tea on the metabolic syndrome. Thirty-five individuals (average age 42.5 years) with an average BMI of 36 kg/m 2 were provided with green tea in bags (four cups a day), green tea extract capsules (two a day, total 800 mg of catechins), or a placebo for 2 months. There were no differences in parameters of the metabolic syndrome among groups or in proinflammatory cytokine levels [70] . Some other studies did not find positive results for obesity-related measures. For example 12-week green tea supplementation to a low-energy diet, independent of habitual caffeine intake, had no effect on measures of body weight or body composition in overweight women at either 4 weeks or 3 months [71] . Similar non-significant findings were observed in an EGCG-supplemented group of overweight/obese postmenopausal women who attended regular aerobic exercise [72] . Lack of beneficial impact of green tea extract on obesity was also reported in obese children [73] .
Phytopreparations of grape seeds:
Several clinical studies examined the effects of grape seed products on obesity-related energy expenditure, fat oxidation, plasma lipid profiles, glucose hemostasis and inflammation.Twenty-seven individuals, 25 to 80 years old, with metabolic syndrome consumed either 150 to 300 mg/day of grape seed extract or a placebo for 1 month. There was a significant decrease in systolic and diastolic blood pressures in subjects taking either dose of grape seed extract. The higher was the baseline of oxidized LDL, the greater the decrease in oxidized LDL with a 300 mg dose [74] . In another study, forty-four women (premenopausal, mean age 39.7 years, and postmenopausal, mean age 58.5 years) consumed 36 g/day of a 182 g lyophilized grape powder per day (equivalent of 1.5 cups/day of grapes) or a sugarsweetened placebo mixed with water for 1 month in a singleblinded crossover investigation. Pre-and postmenopausal women who drank a grape beverage showed lower triacylglycerols by 15% and 6%, respectively. There were no changes in the cytokines TNFα, C-reactive protein, or IL-6 [75] .
Polyphenol rich cocoa: Several human trials have examined the effect of polyphenol-rich cocoa on lipid levels. The polyphenols found in cocoa, augment nitric oxide production [76] . In a recent study, eight patients with coronary artery disease were given cocoa drinks containing a 375 mg dose of cocoa polyphenols twice a day for 1 month. Their brachial arteries had an improved vasodilatory capacity, and they were able to produce larger numbers of endothelial progenitor cells. The systolic blood pressure of those subjects taking the dose of cocoa decreased, which was not seen in another group that consumed only 9 mg twice a day [77] . Meta-1882 Natural Product Communications Vol. 10 (11) 2015 Sieniawska analyses of human trials have concluded that cocoa induces slight decrease in total cholesterol and LDL and that coca can lower systolic blood pressure by 4.5 mmHg and diastolic blood pressure by 2.5 mmHg [78, 79] .
Cranberry phytopreparations:
The meta-analyses of data of all randomized controlled trials (RCTs) or quasi-RCTs of cranberry products for the prevention of urinary tract infections showed that, compared with placebo, water or no treatment, cranberry products did not significantly reduce the occurrence of symptomatic urinary tract infections overall or for any of the subgroups: women with recurrent urinary tract infections; older people; pregnant women; children with recurrent urinary tract infections; cancer patients; or people with neuropathic bladder or spinal injury. The effectiveness of cranberry was not significantly different to antibiotics for women and children. Many studies reported low compliance and high withdrawal/dropout problems which they attributed to palatability/acceptability of the products, primarily the cranberry juice. Most studies of other cranberry products (tablets and capsules) did not report how much of the 'active' ingredient the product contained, and, therefore, the products may not have had enough potency to be effective [80, 81] .
Hawthorn extracts: Fourteen clinical trials were used in the metaanalysis of effectiveness of hawthorn extract for treating chronic heart failure. In most of the studies, hawthorn was used as an adjunct to conventional treatment. Ten trials including 855 patients with chronic heart failure (New York Heart Association classes I to III) provided data that were suitable for meta-analysis. For the physiological outcome of maximal workload, treatment with hawthorn extract was more beneficial than placebo. Exercise tolerance was significantly increased by hawthorn extract. The pressure-heart rate product, an index of cardiac oxygen consumption, also showed a beneficial decrease with hawthorn treatment. Symptoms such as shortness of breath and fatigue improved significantly with hawthorn treatment as compared with placebo [82] .
Pycnogenol: Pycnogenol is a patented specific blend of procyanidins extracted from the bark of the pine (Pinus pinaster Aiton., formerly known as P. maritima Mill.). Pycnogenol is used for treating circulation problems, allergies, asthma, ringing in the ears, high blood pressure, muscle soreness, pain, osteoarthritis, diabetes, attention deficit-hyperactivity disorder (ADHD), a disease of the female reproductive system called endometriosis, menopausal symptoms, painful menstrual periods, erectile dysfunction, and an eye disease called retinopathy. It is also used for preventing disorders of the heart and blood vessels, including stroke, heart disease, and varicose veins. Pycnogenol is used to slow the aging process, maintain healthy skin, improve athletic endurance, and improve male fertility [83] .
Randomized controlled trials evaluating the effectiveness of Pycnogenol ® in adults or children with any chronic disorder were included in the meta analysis. Fifteen trials with a total of 791 participants have evaluated Pycnogenol ® for the treatment of seven different chronic disorders. These included asthma (two studies; N = 86), attention deficit hyperactivity disorder (one study; N = 61), chronic venous insufficiency (two studies; N = 60), diabetes mellitus (four studies; N = 201), erectile dysfunction (one study; N = 21), hypertension (two studies; N = 69) and osteoarthritis (three studies; N = 293). Two of the studies were conducted exclusively in children; the others involved adults. However, due to small sample size, limited numbers of trials per condition, variation in outcomes evaluated and outcome measures used, as well as the risk of bias in the included studies, no definitive conclusions regarding the efficacy or safety of Pycnogenol ® are possible [84] .
Conclusions:
This review shows a wide range of studied activities of tannins and reflects the gap between in vitro and iv vivo testing and clinical trials. This gap is obvious when the physiological processes taking place during tannins ingestion, absorption, and metabolism are considered. The chemical properties and molecular mass as well as intestinal bacterial interactions with tannins influence their bioavailability.However, in vitro and in vivo testing is a first step to clinical trials. Clinical trials are usually conducted using plant extracts rich in tannins or functional food instead of purified compounds and they show that many laboratory tests often do not have confirmation in experiments on humans. The results of clinical trials strongly depend on the participating subjects, their health conditions and accompanying diseases. What is more, clinical trials investigating the same compounds may produce inconsistent results, but they shed light on the actual usefulness and health benefits given by tannins.
